One of the most common worries about titanium dioxide is that it could be a cancer-causing agent. The link between cancer and titanium dioxide traces back to a 1985 study where rats were exposed to high levels of titanium dioxide for two years, causing lung cancer. However, not all experts are convinced by this study.

In recent years, environmental concerns have shaped the way lithopone is produced and used. Suppliers are now more attentive to the sustainability aspect of their operations, ensuring that lithopone is sourced from eco-friendly processes. Many suppliers have adopted responsible mining practices and have invested in technologies that reduce waste and emissions during production. This shift not only appeals to environmentally-conscious consumers but also helps manufacturers comply with stringent regulations regarding product safety and environmental impact.

You can find more information about EFSA’s work in the area of food additives on our website

In a 2017 study published in Scientific Reports, researchers exposed rats to human-relevant levels of E171 to examine the effects of intestinal inflammation and carcinogenesis. They saw that “a 100-day E171 treatment promoted colon microinflammation and initiated preneoplastic lesions while also fostering the growth of aberrant crypt foci in a chemically induced carcinogenesis model.” They continued: “Stimulation of immune cells isolated from Peyer’s Patches [which are clusters of lymphoid follicles found in the intestine] showed a decrease in Thelper (Th)-1 IFN-γ secretion, while splenic Th1/Th17 inflammatory responses sharply increased,” researchers wrote. “A 100-day titanium dioxide treatment promoted colon microinflammation and initiated preneoplastic lesions.” The scientists concluded: “These data should be considered for risk assessments of the susceptibility to Th17-driven autoimmune diseases and to colorectal cancer in humans exposed to TiO2 from dietary sources.”

Importance in Factory Settings